News Bad Brexit deal threatens plan to hire NHS staff Jeremy Hunt admits a bad Brexit deal could threaten plans to hire more NHS staff.
News Pharma welcomes dialogue with politicians ahead of election Conservative and Labour politicians assure industry with warm words at conference.
News JPM: AbbVie pays $650m upfront for RemeGen cancer drug AbbVie joins the ranks of companies developing cancer drugs that target both PD-1 and VEGF, via a $5.6bn licensing deal with China's RemeGen.
Sales & Marketing Sponsored How to meet your physicians where they are online A pharma company’s core mission is to improve patient outcomes. This hinges on effectively influencing HCP clinical behaviour and driving disease education.